Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine

F. Castiglione, G. Del Vecchio Blanco, A. Rispo, A. Cozzolino, E. Di Girolamo, D. Cappuccio, G. Mazzacca

Research output: Contribution to journalArticle

Abstract

Azathioprine-related side-effects occur in about 15% of treated patients. Liver toxicity is a rare complication of this drug, but is considered, in most cases, a contraindication to the continuation of treatment. However, abnormal liver tests may occur in patients under azathioprine treatment also due to infections. The distinction between toxic and infective causes of abnormal liver tests is important in order to identify patients that can be rechallenged with the drug. Cytomegalovirus infection is common in immunosuppressed transplant recipients, while the incidence is lower in patients with inflammatory bowel disease treated with immunosuppressive drugs. To our knowledge, only 2 cases of cytomegalovirus hepatitis occurring during azathioprine treatment for Crohn's disease had been reported so far. Here, we describe two patients who experienced mild hepatitis associated with the onset of cytomegalovirus infection during azathioprine treatment. The infection was documented by the appearance of IgM anti cytomegalovirus. Both cases were self-limiting. In one of the 2 patients, azathioprine was given again after resolution of the hepatitis with good control of Crohn's disease and without other complications. We also retrospectively evaluated the incidence of liver abnormalities assessed by blood tests in 58 consecutive patients with Crohn's disease treated with azathioprine at our institution. Abnormal results were obtained in 8 out of these 58 patients, requiring discontinuation of the drug in 3 patients, two of whom were the cytomegalovirus cases described above.

Original languageEnglish
Pages (from-to)626-629
Number of pages4
JournalDigestive and Liver Disease
Volume32
Issue number7
Publication statusPublished - 2000

Fingerprint

Azathioprine
Cytomegalovirus Infections
Crohn Disease
Hepatitis
Cytomegalovirus
Liver
Pharmaceutical Preparations
Poisons
Incidence
Hematologic Tests
Therapeutics
Immunosuppressive Agents
Infection
Inflammatory Bowel Diseases

Keywords

  • Azathioprine
  • Chron's disease
  • Cytomegalovirus infection
  • Hepatitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Castiglione, F., Del Vecchio Blanco, G., Rispo, A., Cozzolino, A., Di Girolamo, E., Cappuccio, D., & Mazzacca, G. (2000). Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Digestive and Liver Disease, 32(7), 626-629.

Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. / Castiglione, F.; Del Vecchio Blanco, G.; Rispo, A.; Cozzolino, A.; Di Girolamo, E.; Cappuccio, D.; Mazzacca, G.

In: Digestive and Liver Disease, Vol. 32, No. 7, 2000, p. 626-629.

Research output: Contribution to journalArticle

Castiglione, F, Del Vecchio Blanco, G, Rispo, A, Cozzolino, A, Di Girolamo, E, Cappuccio, D & Mazzacca, G 2000, 'Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine', Digestive and Liver Disease, vol. 32, no. 7, pp. 626-629.
Castiglione F, Del Vecchio Blanco G, Rispo A, Cozzolino A, Di Girolamo E, Cappuccio D et al. Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Digestive and Liver Disease. 2000;32(7):626-629.
Castiglione, F. ; Del Vecchio Blanco, G. ; Rispo, A. ; Cozzolino, A. ; Di Girolamo, E. ; Cappuccio, D. ; Mazzacca, G. / Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. In: Digestive and Liver Disease. 2000 ; Vol. 32, No. 7. pp. 626-629.
@article{38e10723c2bc44549e6d1d1dcc0e841c,
title = "Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine",
abstract = "Azathioprine-related side-effects occur in about 15{\%} of treated patients. Liver toxicity is a rare complication of this drug, but is considered, in most cases, a contraindication to the continuation of treatment. However, abnormal liver tests may occur in patients under azathioprine treatment also due to infections. The distinction between toxic and infective causes of abnormal liver tests is important in order to identify patients that can be rechallenged with the drug. Cytomegalovirus infection is common in immunosuppressed transplant recipients, while the incidence is lower in patients with inflammatory bowel disease treated with immunosuppressive drugs. To our knowledge, only 2 cases of cytomegalovirus hepatitis occurring during azathioprine treatment for Crohn's disease had been reported so far. Here, we describe two patients who experienced mild hepatitis associated with the onset of cytomegalovirus infection during azathioprine treatment. The infection was documented by the appearance of IgM anti cytomegalovirus. Both cases were self-limiting. In one of the 2 patients, azathioprine was given again after resolution of the hepatitis with good control of Crohn's disease and without other complications. We also retrospectively evaluated the incidence of liver abnormalities assessed by blood tests in 58 consecutive patients with Crohn's disease treated with azathioprine at our institution. Abnormal results were obtained in 8 out of these 58 patients, requiring discontinuation of the drug in 3 patients, two of whom were the cytomegalovirus cases described above.",
keywords = "Azathioprine, Chron's disease, Cytomegalovirus infection, Hepatitis",
author = "F. Castiglione and {Del Vecchio Blanco}, G. and A. Rispo and A. Cozzolino and {Di Girolamo}, E. and D. Cappuccio and G. Mazzacca",
year = "2000",
language = "English",
volume = "32",
pages = "626--629",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "7",

}

TY - JOUR

T1 - Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine

AU - Castiglione, F.

AU - Del Vecchio Blanco, G.

AU - Rispo, A.

AU - Cozzolino, A.

AU - Di Girolamo, E.

AU - Cappuccio, D.

AU - Mazzacca, G.

PY - 2000

Y1 - 2000

N2 - Azathioprine-related side-effects occur in about 15% of treated patients. Liver toxicity is a rare complication of this drug, but is considered, in most cases, a contraindication to the continuation of treatment. However, abnormal liver tests may occur in patients under azathioprine treatment also due to infections. The distinction between toxic and infective causes of abnormal liver tests is important in order to identify patients that can be rechallenged with the drug. Cytomegalovirus infection is common in immunosuppressed transplant recipients, while the incidence is lower in patients with inflammatory bowel disease treated with immunosuppressive drugs. To our knowledge, only 2 cases of cytomegalovirus hepatitis occurring during azathioprine treatment for Crohn's disease had been reported so far. Here, we describe two patients who experienced mild hepatitis associated with the onset of cytomegalovirus infection during azathioprine treatment. The infection was documented by the appearance of IgM anti cytomegalovirus. Both cases were self-limiting. In one of the 2 patients, azathioprine was given again after resolution of the hepatitis with good control of Crohn's disease and without other complications. We also retrospectively evaluated the incidence of liver abnormalities assessed by blood tests in 58 consecutive patients with Crohn's disease treated with azathioprine at our institution. Abnormal results were obtained in 8 out of these 58 patients, requiring discontinuation of the drug in 3 patients, two of whom were the cytomegalovirus cases described above.

AB - Azathioprine-related side-effects occur in about 15% of treated patients. Liver toxicity is a rare complication of this drug, but is considered, in most cases, a contraindication to the continuation of treatment. However, abnormal liver tests may occur in patients under azathioprine treatment also due to infections. The distinction between toxic and infective causes of abnormal liver tests is important in order to identify patients that can be rechallenged with the drug. Cytomegalovirus infection is common in immunosuppressed transplant recipients, while the incidence is lower in patients with inflammatory bowel disease treated with immunosuppressive drugs. To our knowledge, only 2 cases of cytomegalovirus hepatitis occurring during azathioprine treatment for Crohn's disease had been reported so far. Here, we describe two patients who experienced mild hepatitis associated with the onset of cytomegalovirus infection during azathioprine treatment. The infection was documented by the appearance of IgM anti cytomegalovirus. Both cases were self-limiting. In one of the 2 patients, azathioprine was given again after resolution of the hepatitis with good control of Crohn's disease and without other complications. We also retrospectively evaluated the incidence of liver abnormalities assessed by blood tests in 58 consecutive patients with Crohn's disease treated with azathioprine at our institution. Abnormal results were obtained in 8 out of these 58 patients, requiring discontinuation of the drug in 3 patients, two of whom were the cytomegalovirus cases described above.

KW - Azathioprine

KW - Chron's disease

KW - Cytomegalovirus infection

KW - Hepatitis

UR - http://www.scopus.com/inward/record.url?scp=0033661613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033661613&partnerID=8YFLogxK

M3 - Article

C2 - 11142564

AN - SCOPUS:0033661613

VL - 32

SP - 626

EP - 629

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 7

ER -